Literature DB >> 3197397

The reactivity of p-nitrophenyl acetate with serum albumins.

A Awad-Elkarim1, G E Means.   

Abstract

1. Serum albumins from nine of 10 vertebrate species were found to react rapidly with p-nitrophenylacetate. 2. The high reactivities were shown to be partially attributable to strong, rapidly reversible binding of p-nitrophenylacetate by each serum albumin. 3. As previously observed in the case of human serum albumin (Koh and Means, Arch. Biochem. Biophys. 192, 73-79, 1979), this binding takes place in the primary binding site for several physiologically (i.e. tryptophan, small fatty acid anions) and pharmacologically (i.e. diazepam) important compounds. 4. Horse serum albumin differed from all other serum albumins included in this study in that it did not react rapidly with p-nitrophenylacetate, presumably, due to significant differences in its corresponding binding site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197397     DOI: 10.1016/0305-0491(88)90141-1

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  4 in total

1.  Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity.

Authors:  H Watanabe; S Tanase; K Nakajou; T Maruyama; U Kragh-Hansen; M Otagiri
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  Mass Spectrometry-Based Protein Footprinting for Higher-Order Structure Analysis: Fundamentals and Applications.

Authors:  Xiaoran Roger Liu; Mengru Mira Zhang; Michael L Gross
Journal:  Chem Rev       Date:  2020-04-22       Impact factor: 60.622

3.  Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate.

Authors:  Adam V Wisnewski; Jian Liu; Carrie A Redlich
Journal:  Anal Biochem       Date:  2010-02-01       Impact factor: 3.365

4.  Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates.

Authors:  Yuji Sakurai; Shen-Feng Ma; Hiroshi Watanabe; Noriyuki Yamaotsu; Shuichi Hirono; Yukihisa Kurono; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.